Skip to main content
. 2010 Feb 23;102(6):1003–1009. doi: 10.1038/sj.bjc.6605587

Figure 2.

Figure 2

Kaplan–Meier illustrating impact of CYP2B6*2 genotype on progression-free survival (A) and OS (B) of breast cancer patients treated with adjuvant AC therapy with intention to cure. Curves are categorised by heterozygotes (dashed line) vs wild-type homozygotes (solid line). Equality of survival distribution was tested by log rank.